Sort
48,018 grants matching “immunotherapy”
Targeted activation of autoimmune checkpoints in B cell malignancies
$398,548Markus Mãschen · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA
Tumor microenvironment at single cell level in black and white NSCLC patients
$398,545Wei Zhang · Wake Forest University Health Sciences · R21 · FY2020 · CA
Role of Ly6K in TGF-beta and immune escape pathways of triple negative breast cancer
$398,541Geeta Upadhyay · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2020 · CA
Mechanisms of Vaccinia Virus Innate Immune Inhibition
$398,531William Lawrence Marshall · Univ Of Massachusetts Med Sch Worcester · R01 · FY2008 · AI
Mechanisms of Vaccinia Virus Innate Immune Inhibition
$398,531William Lawrence Marshall · Univ Of Massachusetts Med Sch Worcester · R01 · FY2009 · AI
Image-guided irreversible electroporation directed CAR T-cell delivery to solid tumors
$398,509Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Lymph Node-Targeted Codelivery of Albumin-Binding Peptide Antigens and Di-Adjuvant for Melanoma Combination Immunotherapy
$398,500Guizhi Zhu · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Single-cell dynamic analysis to improve the biomanufacturing process for engineering of cell therapy products
$398,495Tania Konry · Northeastern University · · FY2023 · ENG
Regulation of Macrophage- and Microglia-mediated STING Signaling in Glioblastoma
$398,459Rongze Olivia Lu · University Of California, San Francisco · R01 · FY2022 · NS
Cancer Center Research Training Program
$398,438John M Maris · University Of Pennsylvania · T32 · FY2016 · CA
Arenavirus Receptor-Structure/Function Studies
$398,428Michael B Oldstone · Scripps Research Institute, The · R01 · FY2008 · AI
Development of a Novel Resolvin-Based Therapy for Treatment of Pancreatic Cancer
$398,404John Parkinson · Thetis Pharmaceuticals, Llc · R44 · FY2023 · CA
Informatics for Functional Integration of Heterogeneous Cancer Genome and Transcriptome Sequencing Data
$398,399Ken Chen · University Of Tx Md Anderson Can Ctr · U01 · FY2020 · CA
An In Situ Patient-specific Chemo-Immunotherapy for Skin Cancers
$398,375Louis D Falo · University Of Pittsburgh At Pittsburgh · P50 · FY2015 · CA
Regulation of Tumor Oxygenation by BACH1 in Breast Cancer
$398,285Marsha R Rosner · University Of Chicago · R01 · FY2023 · CA
Abbreviated targeted therapy to improve anti-PD-1 inhibitor efficacy in melanoma
$398,271Ryan J Sullivan · Massachusetts General Hospital · R01 · FY2018 · CA
Role of cGAS-STING in Afterload-Induced Cardiac Remodeling
$398,271Joseph A. Hill · University Of Arizona · P01 · FY2025 · HL
Development of a small-molecule immunomodulator for the treatment of melanoma
$398,242Rukiyah Van Dross · Claradele Pharmaceuticals, Inc. · R41 · FY2022 · CA
Fruit exosome-like particles for therapeutic delivery of extracellular miRNAs
$398,220Huang-Ge Zhang · University Of Louisville · UH2 · FY2013 · TR
Clinical trial development in cancer vaccines
$398,219Samir Khleif · Basic Sciences · Z01 · FY2007 · CA
Tumor Immunology Institutional Training Grant
$398,208Steven M. Dubinett · University Of California Los Angeles · T32 · FY2006 · CA
Targeting T Cell Senescence and Dysfunction for Anti-tumor Immunity
$398,204Guangyong Peng · Saint Louis University · R01 · FY2022 · CA
Cancer Immunotherapy Targeting Tn Antigen
$398,178Michael Demetriou · Glytr Therapeutics, Inc. · R41 · FY2021 · CA
ALLOGENIC PANCREATIC TUMOR VACCINE CELL LINE
$398,129Johns Hopkins University · R01 · FY2003 · CA
Investigating the prognostic role of intrinsic immune evasion mechanisms in HNSCC
$398,052Xuefeng Wang · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · DE